Vycor Medical, Inc. (VYCO)
USD 0.07
(24.05%)
USD 0.07
(24.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 40.19 Thousand USD | 113.11% |
| 2022 | -306.51 Thousand USD | 29.69% |
| 2021 | -435.95 Thousand USD | 39.57% |
| 2020 | -721.39 Thousand USD | 0.52% |
| 2019 | -725.12 Thousand USD | 44.97% |
| 2018 | -1.31 Million USD | -0.39% |
| 2017 | -1.31 Million USD | 17.52% |
| 2016 | -1.59 Million USD | 20.07% |
| 2015 | -1.99 Million USD | 27.13% |
| 2014 | -2.73 Million USD | -19.75% |
| 2013 | -2.28 Million USD | 18.35% |
| 2012 | -2.79 Million USD | 39.62% |
| 2011 | -4.62 Million USD | -201.96% |
| 2010 | -1.53 Million USD | -62.58% |
| 2009 | -942.6 Thousand USD | 35.92% |
| 2008 | -1.47 Million USD | -202.49% |
| 2007 | -486.32 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9530.00 USD | 85.12% |
| 2024 Q2 | 16.18 Thousand USD | 269.76% |
| 2023 Q4 | -64.05 Thousand USD | -151.39% |
| 2023 Q1 | 33.2 Thousand USD | 136.41% |
| 2023 Q2 | 96.52 Thousand USD | 190.65% |
| 2023 Q3 | -25.48 Thousand USD | -126.4% |
| 2023 FY | 40.19 Thousand USD | 113.11% |
| 2022 FY | -306.51 Thousand USD | 29.69% |
| 2022 Q1 | -52.89 Thousand USD | 67.78% |
| 2022 Q2 | -74.37 Thousand USD | -40.6% |
| 2022 Q3 | -88.04 Thousand USD | -18.38% |
| 2022 Q4 | -91.19 Thousand USD | -3.58% |
| 2021 FY | -435.95 Thousand USD | 39.57% |
| 2021 Q3 | -88.39 Thousand USD | -476.33% |
| 2021 Q4 | -164.19 Thousand USD | -85.75% |
| 2021 Q2 | 23.48 Thousand USD | 111.36% |
| 2021 Q1 | -206.84 Thousand USD | -18.22% |
| 2020 Q3 | -206.37 Thousand USD | -3.52% |
| 2020 Q1 | -156.39 Thousand USD | 23.09% |
| 2020 Q2 | -199.35 Thousand USD | -27.47% |
| 2020 Q4 | -174.96 Thousand USD | 15.22% |
| 2020 FY | -721.39 Thousand USD | 0.52% |
| 2019 Q3 | -191.67 Thousand USD | -14.58% |
| 2019 FY | -725.12 Thousand USD | 44.97% |
| 2019 Q1 | -162.83 Thousand USD | 64.97% |
| 2019 Q2 | -167.28 Thousand USD | -2.73% |
| 2019 Q4 | -203.33 Thousand USD | -6.08% |
| 2018 Q1 | -314.55 Thousand USD | 13.43% |
| 2018 FY | -1.31 Million USD | -0.39% |
| 2018 Q2 | -405.64 Thousand USD | -28.96% |
| 2018 Q4 | -464.81 Thousand USD | -250.21% |
| 2018 Q3 | -132.72 Thousand USD | 67.28% |
| 2017 Q3 | -295.6 Thousand USD | 16.47% |
| 2017 FY | -1.31 Million USD | 17.52% |
| 2017 Q4 | -363.35 Thousand USD | -22.92% |
| 2017 Q2 | -353.89 Thousand USD | -18.07% |
| 2017 Q1 | -299.72 Thousand USD | 36.21% |
| 2016 FY | -1.59 Million USD | 20.07% |
| 2016 Q4 | -469.87 Thousand USD | -49.06% |
| 2016 Q1 | -514.77 Thousand USD | -23.92% |
| 2016 Q3 | -315.22 Thousand USD | -8.14% |
| 2016 Q2 | -291.5 Thousand USD | 43.37% |
| 2015 Q1 | -608.31 Thousand USD | -1.7% |
| 2015 FY | -1.99 Million USD | 27.13% |
| 2015 Q3 | -509.17 Thousand USD | -11.15% |
| 2015 Q2 | -458.09 Thousand USD | 24.7% |
| 2015 Q4 | -415.41 Thousand USD | 18.41% |
| 2014 Q2 | -703.6 Thousand USD | 29.11% |
| 2014 Q4 | -598.13 Thousand USD | -36.63% |
| 2014 Q3 | -437.78 Thousand USD | 37.78% |
| 2014 Q1 | -992.53 Thousand USD | -68.79% |
| 2014 FY | -2.73 Million USD | -19.75% |
| 2013 Q2 | -609.61 Thousand USD | -1.67% |
| 2013 Q4 | -588.04 Thousand USD | -21.45% |
| 2013 Q3 | -484.2 Thousand USD | 20.57% |
| 2013 Q1 | -599.62 Thousand USD | -13.34% |
| 2013 FY | -2.28 Million USD | 18.35% |
| 2012 Q3 | -762.37 Thousand USD | -2.65% |
| 2012 Q2 | -742.71 Thousand USD | 2.27% |
| 2012 Q4 | -529.04 Thousand USD | 30.61% |
| 2012 Q1 | -759.94 Thousand USD | 4.98% |
| 2012 FY | -2.79 Million USD | 39.62% |
| 2011 Q1 | -782.47 Thousand USD | -53.45% |
| 2011 Q2 | -1.8 Million USD | -130.77% |
| 2011 Q3 | -1.11 Million USD | 38.51% |
| 2011 Q4 | -799.77 Thousand USD | 27.97% |
| 2011 FY | -4.62 Million USD | -201.96% |
| 2010 Q3 | -281.69 Thousand USD | 35.1% |
| 2010 Q2 | -434.03 Thousand USD | -41.44% |
| 2010 Q1 | -306.86 Thousand USD | 10.95% |
| 2010 FY | -1.53 Million USD | -62.58% |
| 2010 Q4 | -509.93 Thousand USD | -81.02% |
| 2009 FY | -942.6 Thousand USD | 35.92% |
| 2009 Q2 | -197.07 Thousand USD | 29.96% |
| 2009 Q3 | -119.54 Thousand USD | 39.34% |
| 2009 Q1 | -281.38 Thousand USD | -2.91% |
| 2009 Q4 | -344.6 Thousand USD | -188.26% |
| 2008 Q1 | -484.96 Thousand USD | 0.0% |
| 2008 Q4 | -273.41 Thousand USD | 15.12% |
| 2008 Q3 | -322.1 Thousand USD | 17.53% |
| 2008 FY | -1.47 Million USD | -202.49% |
| 2008 Q2 | -390.59 Thousand USD | 19.46% |
| 2007 FY | -486.32 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 114.653% |
| IR-Med Inc. | -4.91 Million USD | 100.818% |
| Polarean Imaging plc | -12.55 Million USD | 100.32% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 90.828% |
| Avitar, Inc. | 2.73 Million USD | 98.529% |
| AVITA Medical, Inc. | -40.4 Million USD | 100.099% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 105.717% |
| Össur hf. | 87.46 Million USD | 99.954% |
| Zecotek Photonics Inc. | -3.65 Million USD | 101.099% |
| QHSLab, Inc. | -240.15 Thousand USD | 116.735% |
| Wellstar International, Inc. | -1.79 Million USD | 102.239% |
| Össur hf. | 87.46 Million USD | 99.954% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 98.069% |
| Escalon Medical Corp. | -104.47 Thousand USD | 138.469% |
| Aurora Spine Corporation | -446.19 Thousand USD | 109.007% |
| BrainsWay Ltd. | -4.92 Million USD | 100.816% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 100.425% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 85.543% |
| Vivos Inc. | -2.79 Million USD | 101.439% |
| MicroPort Scientific Corporation | -516.16 Million USD | 100.008% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 116.805% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 102.269% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 110.607% |
| Nanomix Corporation | -8.43 Million USD | 100.476% |
| Theraclion SA | -3.48 Million USD | 101.155% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 105.684% |
| Positron Corporation | -1.36 Million USD | 102.954% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 101.946% |
| Lombard Medical, Inc. | -29.33 Million USD | 100.137% |
| ALR Technologies Inc. | -2.94 Million USD | 101.364% |
| Stratec SE | 25.26 Million USD | 99.841% |
| Heart Tronics, Inc. | 14.46 Million USD | 99.722% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | 133.346% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 100.194% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 107.443% |
| VMS Rehab Systems, Inc. | -68.66 USD | 58636.266% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 101.163% |
| Ingen Technologies, Inc. | -1.61 Million USD | 102.491% |
| Odyssey Group International, Inc. | 14.26 Million USD | 99.718% |
| United American Healthcare Corporation | -67 Thousand USD | 159.987% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 109.863% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 106.332% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 106.682% |
| Urologix, Inc. | -6.93 Million USD | 100.58% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 103.181% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 100.642% |
| SS Innovations International, Inc. | -20.66 Million USD | 100.194% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 117.456% |
| Smith & Nephew plc | 425 Million USD | 99.991% |
| NIOX Group Plc | 4.6 Million USD | 99.126% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 89.529% |
| Broncus Holding Corporation | -33.22 Million USD | 100.121% |
| Brain Scientific Inc. | -9.6 Million USD | 100.418% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 100.423% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | 166.214% |